Monday, May 10, 2021 8:12:49 AM
Summary
Buyout Target Potential (Bristol Myers-IMF Therapeutics $2.3B)
N2RF6 10X Less Toxic-Most Advanced in industry
VariousCancers, Lupus, Rare Blood & Auto Immune Disease Treatments
Bio Tech-Stem Cell Clinical Stage Company
https://seekingalpha.com/instablog/32618395-small-cap-solutions-llc/5024702-is-regen-biopharma-buyout-target-potential-otcqb-rgbp
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM